Procedural sedation isn’t what it used to be. With the advent of new drug options and the Fear Free® movement, the way we think about sedation in practice is changing. In this episode of the Clinician’s Brief Partner Podcast, host Dr. Beth Molleson sits down with Dr. Mark Besancon to discuss his experience with procedural sedation in practice, including a closer look at Zenalpha® (medetomidine and vatinoxan hydrochlorides injection), a novel alpha-2 combination drug option for procedural sedation in dogs. Sponsored by Dechra Contact us: Podcast@briefmedia.com Where to find us: Cliniciansbrief.com/podcasts Facebook.com/clinciansbrief Twitter: @cliniciansbrief Instagram: @clinicians.brief The Team: Beth Molleson, DVM - Host Sarah Pate - Producer & Project Manager, Brief Studio Randall Stupka - Podcast Production & Sound Editing
Procedural sedation isn’t what it used to be. With the advent of new drug options and the Fear Free® movement, the way we think about sedation in practice is changing. In this episode of the Clinician’s Brief Partner Podcast, host Dr. Beth Molleson sits down with Dr. Mark Besancon to discuss his experience with procedural sedation in practice, including a closer look at Zenalpha® (medetomidine and vatinoxan hydrochlorides injection), a novel alpha-2 combination drug option for procedural sedation in dogs.
Sponsored by Dechra
Contact us:
Where to find us:
The Team: